Cambridge Investment Research Advisors, Inc.
Position in HRTX — Heron Therapeutics, Inc. /De/
CIK 1419186
FAIRFIELD, IA
Position in HRTX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$11,948
-$5,889 QoQ
Shares Held
27,995
+25.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 161 holders
Holding Since
Jun 2021
21 quarters on record
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $60,632,692 across 72 Biotechnology names. HRTX ranks #70 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,946 | $10,901,236 | |
| 2 | EXEL |
Exelixis, Inc.
|
82,212 | $4,473,154 | |
| 3 | NKTR |
Nektar Therapeutics
|
56,186 | $3,922,344 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
35,157 | $3,056,901 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
15,839 | $2,966,327 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,591 | $2,862,672 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
46,210 | $2,520,293 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
30,727 | $2,288,546 |
All Filings in HRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,948 | 27,995 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $17,837 | 22,297 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $34,348 | 26,422 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $33,543 | 26,622 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $57,891 | 27,967 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $61,307 | 27,867 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $15,861 | 10,367 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $23,217 | 11,667 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $52,034 | 14,867 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $30,101 | 10,867 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $20,173 | 11,867 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $16,085 | 15,617 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $20,319 | 17,517 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $27,205 | 18,017 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $43,292 | 17,317 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $77,297 | 18,317 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $51,104 | 18,317 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $113,353 | 19,817 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $180,554 | 19,776 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $162,872 | 15,236 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $235,981 | 15,205 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||